158 related articles for article (PubMed ID: 24348856)
1. hTERT promoter activity identifies osteosarcoma cells with increased EMT characteristics.
Yu L; Liu S; Guo W; Zhang C; Zhang B; Yan H; Wu Z
Oncol Lett; 2014 Jan; 7(1):239-244. PubMed ID: 24348856
[TBL] [Abstract][Full Text] [Related]
2. Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity.
Yu L; Liu S; Zhang C; Zhang B; Simões BM; Eyre R; Liang Y; Yan H; Wu Z; Guo W; Clarke RB
Oncotarget; 2013 Dec; 4(12):2326-38. PubMed ID: 24334332
[TBL] [Abstract][Full Text] [Related]
3. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin promotes mesenchymal-like characteristics in osteosarcoma through Snail.
Fang S; Yu L; Mei H; Yang J; Gao T; Cheng A; Guo W; Xia K; Liu G
Oncol Lett; 2016 Dec; 12(6):5007-5014. PubMed ID: 28105207
[TBL] [Abstract][Full Text] [Related]
5. Telomerase reverse transcriptase coordinates with the epithelial-to-mesenchymal transition through a feedback loop to define properties of breast cancer stem cells.
El-Badawy A; Ghoneim NI; Nasr MA; Elkhenany H; Ahmed TA; Ahmed SM; El-Badri N
Biol Open; 2018 Jul; 7(7):. PubMed ID: 29907642
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cell growth and telomerase activity in osteosarcoma cells by DN-hTERT.
Xu T; Rao Y; Zhu W; Guo F
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):601-3. PubMed ID: 17219980
[TBL] [Abstract][Full Text] [Related]
7. BMI-1 activation is crucial in hTERT-induced epithelial-mesenchymal transition of oral epithelial cells.
Qiao B; Chen Z; Hu F; Tao Q; Lam AK
Exp Mol Pathol; 2013 Aug; 95(1):57-61. PubMed ID: 23712029
[TBL] [Abstract][Full Text] [Related]
8. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
Zhang Y; Wang F; Wang L; Zhang Q
World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
[TBL] [Abstract][Full Text] [Related]
9. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
10. Twisted epithelial-to-mesenchymal transition promotes progression of surviving bladder cancer T24 cells with hTERT-dysfunction.
Xue Y; Li L; Zhang D; Wu K; Chen Y; Zeng J; Wang X; He D
PLoS One; 2011; 6(11):e27748. PubMed ID: 22110753
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition and mesenchymal-epithelial transition are essential for the acquisition of stem cell properties in hTERT-immortalised oral epithelial cells.
Qiao B; Gopalan V; Chen Z; Smith RA; Tao Q; Lam AK
Biol Cell; 2012 Aug; 104(8):476-89. PubMed ID: 22548277
[TBL] [Abstract][Full Text] [Related]
12. Human telomerase reverse transcriptase promotes the epithelial to mesenchymal transition in lung cancer cells by enhancing c-MET upregulation.
Prasad RR; Mishra DK; Kumar M; Yadava PK
Heliyon; 2022 Jan; 8(1):e08673. PubMed ID: 35024489
[TBL] [Abstract][Full Text] [Related]
13. Telomerase reverse transcriptase potentially promotes the progression of oral squamous cell carcinoma through induction of epithelial-mesenchymal transition.
Zhao T; Hu F; Qiao B; Chen Z; Tao Q
Int J Oncol; 2015 May; 46(5):2205-15. PubMed ID: 25775973
[TBL] [Abstract][Full Text] [Related]
14. TGF-β-mediated regulation of plasminogen activators is human telomerase reverse transcriptase dependent in cancer cells.
Jaiswal RK; Yadava PK
Biofactors; 2019 Sep; 45(5):803-817. PubMed ID: 31317567
[TBL] [Abstract][Full Text] [Related]
15. Spheroid-Derived Cells From Renal Adenocarcinoma Have Low Telomerase Activity and High Stem-Like and Invasive Characteristics.
Saeednejad Zanjani L; Madjd Z; Rasti A; Asgari M; Abolhasani M; Tam KJ; Roudi R; Mælandsmo GM; Fodstad Ø; Andersson Y
Front Oncol; 2019; 9():1302. PubMed ID: 31921617
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
Song Y; Kong BH; Liu PS; Ma DX; Jiang S
Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
[TBL] [Abstract][Full Text] [Related]
17. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
18. hTERT transcription is repressed by Cbfa1 in human mesenchymal stem cell populations.
Isenmann S; Cakouros D; Zannettino A; Shi S; Gronthos S
J Bone Miner Res; 2007 Jun; 22(6):897-906. PubMed ID: 17352650
[TBL] [Abstract][Full Text] [Related]
19. hTERT promotes tumor progression by enhancing TSPAN13 expression in osteosarcoma cells.
Jaiswal RK; Kumar P; Kumar M; Yadava PK
Mol Carcinog; 2018 Aug; 57(8):1038-1054. PubMed ID: 29722072
[TBL] [Abstract][Full Text] [Related]
20. hTERT promotes the invasion of telomerase-negative tumor cells in vitro.
Yu ST; Chen L; Wang HJ; Tang XD; Fang DC; Yang SM
Int J Oncol; 2009 Aug; 35(2):329-36. PubMed ID: 19578747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
